ASCO 2015 | Current clinical perspectives on targeted therapy and immunotherapy for melanoma
Caroline Robert
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Caroline Robert, MD, PhD, from Institut Gustave Roussy, Villejuif, France, considers the impact of available and emerging targeted therapies and immunotherapies on the current treatment landscape in melanoma.
Related videos
3:05 Producing patient-specific tumor-reactive T-cells
Chiara Cattaneo
1:27 Health-related QoL in ipilimumab treated advanced melanoma survivors
Christian Blank
1:34 OpACIN and OpACIN-neo trial updates
Christian Blank
1:09 Predicting resistance to targeted therapies in melanoma
Christian Blank
5:39 Melanoma musings: Dr Ascierto's trial updates from ESMO
Paolo Ascierto
